Detalhe da pesquisa
1.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Ann Hematol;
2024 Mar 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38438627
2.
A very rare case of FLT3-D835 positive blastic plasmacytoid dendritic cell neoplasm.
Arch Clin Cases;
7(4): 57-62, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34754929